UNIGE document Scientific Article
previous document  unige:19759  next document
add to browser collection

Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond

Davison, K Shawn
Kendler, David L.
Bauer, Douglas C.
Dempster, David W.
Dian, Larry
Hanley, David A.
Harris, Steven T.
show hidden authors show all authors [1 - 11]
Published in The American journal of medicine. 2009, vol. 122, no. 11, p. 992-997
Abstract Although there have been numerous advances in the assessment of bone strength and fracture risk, the majority of these techniques can only be performed in research laboratories, making them largely unavailable to practicing clinicians. Prospective epidemiologic studies have identified risk factors that can be assessed within the clinic and combined with bone mineral density to allow clinicians to better identify untreated individuals at heightened risk for fracture and to make informed treatment decisions based on 10-year absolute fracture risk. This article discusses the assessment of fracture risk in clinical practice, reviews currently and soon-available bone measurement tools, and details the impacts of osteoporosis therapies on fracture risk.
Keywords Absorptiometry, Photon*Bone DensityBone Density Conservation Agents/*therapeutic useFractures, Bone/etiology/*prevention & controlHumansOsteoporosis/complications/*drug therapy/metabolismPrognosis*Risk AssessmentRisk Factors
PMID: 19854322
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Research group Etudes précliniques de l'ostéoporose (606)
(ISO format)
DAVISON, K Shawn et al. Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond. In: The American journal of medicine, 2009, vol. 122, n° 11, p. 992-997. doi: 10.1016/j.amjmed.2009.05.018 https://archive-ouverte.unige.ch/unige:19759

467 hits

0 download


Deposited on : 2012-04-23

Export document
Format :
Citation style :